JBF Capital’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

JBF Capital’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50,000	Closed	-$502K	–	80
2023 Q4	$502K	Buy	+50,000	New	+$227K	0.1%	50

JBF Capital's GRCL Position: Q1 2024 in Review

JBF Capital sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 50,000 shares — an estimated $502K sold.

JBF Capital first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $502K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

JBF Capital reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
JBF Capital sold 50,000 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $502K.
JBF Capital first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
JBF Capital's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $502K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on JBF Capital's 13F filing for Q1 2024, filed 14 May 2024.